The announcement on Thursday came days after the company teamed up with the Indian Army to airlift cryogenic oxygen tanks from Thailand and set up medical oxygen plants across needy states.
66 percent people above 45 years vaccinated against COVID-19 in Jammu and Kashmir
SECTIONS
Last Updated: May 25, 2021, 05:42 PM IST
Share
Synopsis
Jammu and Kashmir is among the leading regions in the country in vaccination of above 45 years age group having vaccinated 66 percent of its eligible population which is well above the national average of 32 percent. Four districts Ganderbal, Jammu, Samba and Shopian have achieved 100 percent coverage in this category, while the remaining districts continue with promising progress.
AFP
A total of 66 percent people above 45 years have been administered COVID-19 vaccine so far in Jammu and Kashmir, officials said on Tuesday. This was conveyed by top J-K officials at a high-level meeting chaired by Union Home Secretary Ajay Kumar Bhalla to review the Covid management across all union territories.
Dr Reddy s developing new treatment options for COVID-19, says MD
SECTIONS
Last Updated: May 23, 2021, 11:21 AM IST
Share
Synopsis We are motivated to serve patients in every possible way and with utmost urgency. This is reflected in the multiple collaborations we have entered to develop and commercialise a wide range of preventive and curative options for COVID treatment, Dr Reddy s Laboratories Co-Chairman & Managing Director G V Prasad said in an analyst call.
Agencies
The Hyderabad-based drug major has already launched Sputnik V vaccine while partnering various organisations, including the Defence Research and Development Organisation.
Drug major Dr Reddy s Laboratories is working on the development of new treatment options for COVID-19 patients which it aims to launch over the next few months while ensuring uninterrupted supplies of its existing range of products for the infectious disease in the market, according to a top company official. The Hyderabad-based drug maj
India News: Drug major Dr Reddy's Laboratories is working on the development of new treatment options for Covid-19 patients which it aims to launch over the next
DRDO develops antibody test kit DIPCOVAN for early detection of COVID-19
DRDO develops antibody test kit DIPCOVAN for early detection of COVID-19
ANI / Updated: May 21, 2021, 17:05 IST
DRDO) has developed an
COVID.
DIPCOVAN, the DIPAS-VDx COVID 19 IgG Antibody Microwell ELISA for sero-surveillance has been developed by the Defence Institute of Physiology and Allied Sciences (DIPAS) in association with Delhi-based firm Vanguard Diagnostics Pvt Ltd.
According to DRDO, the kit can detect spike as well as nucleocapsid (S and N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent. It was developed indigenously by scientists, followed by extensive validation on over 1000 patient samples at various COVID hospitals in Delhi.